Loading...

Daniel Lowenstein, MD

TitleExec VC and Provost
SchoolUCSF Chancellor/EVC/FAS
DepartmentExecutive Vice Chancellor & Provost
Address513 Parnassus Ave, Med Sci
San Francisco CA 94122
Phone415-476-4451
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Clinical Fellowship School of Medicine
    University of California, San FranciscoResidency 1987School of Medicine
    Harvard UniversityM.D.1983Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Daniel H. Lowenstein is the Executive Vice Chancellor and Provost at the University of California, San Francisco (UCSF), the Robert B. and Ellinor Aird Professor and Vice Chairman in the Department of Neurology at the University of California, San Francisco (UCSF), and Director of Physician-Scientist and Education Training Programs for the UCSF School of Medicine.

    Dr. Lowenstein received his B.A. degree in Mathematics from the University of Colorado in 1973, an M.S. degree in Man-Environment Relations from The Pennsylvania State University in 1978, and an M.D. degree from Harvard Medical School in 1983. Following an internship in Pediatrics at UCSF in 1983-84, he completed his residency in Neurology at UCSF from 1984-87, serving as Chief Resident in the final year. He then did a two-year fellowship in Stanley Prusiner's Laboratory, investigating the sequence homology of the PrP gene in various rodent species. He went on to become a faculty member in the Department of Neurology at UCSF, established the UCSF Epilepsy Research Laboratory, and became the Robert B. and Ellinor Aird Professor of Neurology from 1998-2000. He then joined Harvard Medical School (HMS) as the Dean for Medical Education for two and a half years, overseeing a re-organization of curricular governance, the creation of a new educational technology program, the establishment of the HMS Academy (a novel structure for the support of the school’s education mission), and the initial planning for a major revision of the curriculum. In 2003, for family reasons, he moved back to UCSF in his current position.

    Dr. Lowenstein is a clinician-scientist who studies both basic science and clinical aspects of epilepsy. His laboratory studies (carried out from 1989 to 2002) have addressed the fundamental mechanisms of neuronal network remodeling that occur during epileptogenesis; i.e. the process in which a normal network transforms into a hyperexcitable network capable of producing or relaying seizure activity. The main efforts of his research group focused on the various forms of cellular reorganization that are observed in humans with temporal lobe epilepsy, and the parallels between reorganization in the adult nervous system and normal developmental processes. Important findings by his team included the discovery that seizure activity in an adult model of temporal lobe epilepsy causes a marked increase in the birth of hippocampal neurons, and the recognition that numerous molecules responsible for normal development are also expressed in this same brain region in the adult. These studies bear not only on the neurobiology of epilepsy, but also on the broader issue of neurodevelopment and the capacity for regeneration in the adult nervous system after injury.

    In 2002, Dr. Lowenstein turned his attention toward questions related to the genetic basis of common forms of human epilepsy. Working with colleagues from throughout the world, he helped create the Epilepsy Phenome/Genome Project (EPGP), an international, multi-institutional, collaborative study that is collecting detailed phenotype date on 5,250 subjects with specific forms of epilepsy, with the aim of determining the genetic determinants of their disease with whole exome and whole genome sequencing. Having completed the sixth year of the project, EPGP has enrolled more than 4,000 participants and has compiled the most extensive and detailed phenotype dataset in the history of epilepsy research. In 2011, Dr. Lowenstein and colleagues were successful in receiving funding for a new NINDS Epilepsy Center Without Walls entitled “Epi4K: Gene Discovery in 4,000 Epilepsy Genomes”, which has as one of its goals the analysis of the EPGP cohorts. This joint work of EPGP and Epi4K has already yielded major new insights into the genetic basis of the epileptic encephalopathies, a particularly devastating form of epilepsy.

    Dr. Lowenstein's main clinical research to date has been on the management and treatment of patients with status epilepticus; i.e. unusually prolonged seizures. He was the Principal Investigator of a prospective, multi-centered, NINDS-sponsored clinical trial looking at the potential benefits of active treatment of patients in status epilepticus in the pre-hospital setting. This five-year study, completed in 1999, helped define the optimal therapy for these patients nationally. Dr, Lowenstein currently serves as Co-Principal Investigator and member of the Neurological Emergency Treatment Trials (NETT) Clinical Coordinating Center, which oversees a network of academic centers and affiliated hospitals in the U.S. carrying out numerous clinical trials related to acute neurological disease. As part of this effort, he was Co-Principal Investigator with Dr. Robert Silbergleit for the recently completed Rapid Anticonvulsant Medications Prior to Arrival Trial (RAMPART) study, which successfully demonstrated the utility of intramuscular benzodiazepine treatment of status epilepticus in the pre-hospital setting. RAMPART was selected as the “2013 Clinical Trial of the Year” by the Society for Clinical Trials.

    Dr. Lowenstein’s efforts in epilepsy research were recognized by the American Epilepsy Society’s 2001 Basic Research Award, an honor given each year to the foremost basic science investigator whose research “contributes importantly to understanding and conquering epilepsy.” He also served as president of the American Epilepsy Society in 2003-04, and was selected as the 2012 recipient of the Lennox Award, given to “a clinician-scientist who is felt to be among the most outstanding investigators in the field of epilepsy research." This year, he received an Ambassador Award from the International League Against Epilepsy (ILAE) “in recognition of outstanding international contributions to the cause of epilepsy.” He was also recently appointed as Chair of the ILAE Genetics Commission for the next four years.

    Dr. Lowenstein has also been actively involved in defining scientific policy at the national level, having served a 4-year term as a member of the Advisory Council of the National Institute of Neurological Disorders and Stroke (NINDS) and Chair of the NINDS Clinical Trials Subcommittee from 2000-2004. He has also been the Chair of the NINDS Epilepsy Benchmarks Committee since its inception in 2000, and Chair of the NINDS Epilepsy Common Date Elements (CDE) Committee since its formation in 2008.

    In addition to his research interests, Dr. Lowenstein is an avid and highly-regarded teacher, and he has had an active role at UCSF concerning issues related to cultural diversity and civil rights. In recognition of his leadership at UCSF in these areas, as well as his long-standing advocacy for students, staff and faculty of all backgrounds, he received the 1998 Black Student Health Association’s Faculty Award, the 1998 UCSF Dr. Martin Luther King, Jr. Award, the 2006 Holly Smith Award for Exceptional Service to the UCSF School of Medicine, the 2009 UCSF Chancellor’s Award for Public Service, and the 2015 UCSF Chancellor’s Award for Disability Services. In 2013, he was selected by the UCSF community to deliver “The Last Lecture” (see: http://youtu.be/ymAlnYRuBOA).

    Regarding his teaching accomplishments, Dr. Lowenstein has received essentially every major award related to medical student education granted both locally at UCSF and nationally. He received multiple awards from the 1st and 2nd year classes at UCSF, including those for "A Major Contribution to Teaching," "Outstanding Lecture," "Outstanding Lecture Series," and "An Outstanding Role Model." Other major awards include the 1992 UCSF Academic Senate Distinction in Teaching Award, the 1993 and 1998 UCSF Kaiser Award for Excellence in Teaching, the UCSF Class of 1995 John V. Carbone Award for Excellence in Teaching, and Faculty Teaching Awards in 1994 and 1996. Dr. Lowenstein has given the Keynote Address for graduating medical students at Commencement Ceremonies at UCSF four times. In 1996, the UCSF students awarded him the American Medical Student Association (AMSA) Golden Apple Award for Excellence in Teaching. He went on to receive the AMSA 1997 National Golden Apple for Teaching Excellence Award, which is given to one medical school teacher in the country each year. In addition, the American Neurological Association (ANA) named him the first recipient of the ANA Distinguished Teacher Award in 1997, and in 1998 he was granted the Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award by the American Association of Medical Colleges.

    In addition to his professional activities, Dr. Lowenstein is an avid skier and wilderness traveller who has hiked, climbed and canoed extensively throughout the world, including mountaineering and canoe expeditions in Asia, Central and South America, Canada and the United States.


    Collapse Research 
    Collapse Research Activities and Funding
    From New Models to Novel Therapeutics
    NIH/OD, The Jackson Laboratory Center for Precision Genetics U54OD020351-01Aug 15, 2015 - Jun 30, 2020
    Role: Co-investigator
    Established Status Epilepticus Treatment Trial (ESETT)
    NINDS U01NS088034-01Sep 30, 2014 - Aug 31, 2019
    Role: Co-leader, clinical adjudication core
    The Human Epilepsy Project
    Epilepsy Study Consortium; UCB Pharma; Finding a Cure for Epilepsy and Seizures Jan 1, 2012 - Dec 31, 2018
    Role: P.I
    Epi4K - Administrative Core
    NINDS U01NS077274-01Oct 1, 2011 - Sep 30, 2017
    Role: Principal Investigator
    Epi4K - Phenotyping and Clinical Informatics Core
    NINDS UNS077276-01Oct 1, 2011 - Sep 30, 2017
    Role: Co-P.I.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Goldenholz DM, Goldenholz SR, Moss R, French J, Lowenstein D, Kuzniecky R, Haut S, Cristofaro S, Detyniecki K, Hixson J, Karoly P, Cook M, Strashny A, Theodore WH, Pieper C. Does accounting for seizure frequency variability increase clinical trial power? Epilepsy Res. 2017 Jul 25. PMID: 28781216.
      View in: PubMed
    2. Bramswig NC, Lüdecke HJ, Hamdan FF, Altmüller J, Beleggia F, Elcioglu NH, Freyer C, Gerkes EH, Demirkol YK, Knupp KG, Kuechler A, Li Y, Lowenstein D, Michaud JL, Park K, Stegmann APA, Veenstra-Knol HE, Wieland T, Wollnik B, Engels H, Strom TM, Kleefstra T, Wieczorek D. Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability. Hum Genet. 2017 Jul; 136(7):821-834. PMID: 28393272.
      View in: PubMed
    3. Kleen JK, Lowenstein D. Progress in Epilepsy: Latest Waves of Discovery. JAMA Neurol. 2017 Feb 01; 74(2):139-140. PMID: 27918766.
      View in: PubMed
    4. Robbins NM, Larimer P, Bourgeois JA, Lowenstein D. Number of patient-reported allergies helps distinguish epilepsy from psychogenic nonepileptic seizures. Epilepsy Behav. 2016 Feb; 55:174-7. PMID: 26803428; PMCID: PMC4747833 [Available on 02/01/17].
    5. Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, Bare M, Bleck T, Dodson WE, Garrity L, Jagoda A, Lowenstein D, Pellock J, Riviello J, Sloan E, Treiman DM. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb; 16(1):48-61. PMID: 26900382; PMCID: PMC4749120.
    6. Tan NC, Lowenstein D. Improving your genetic literacy in epilepsy-A new series. Epilepsia. 2015 Nov; 56(11):1696-9. PMID: 26497638.
      View in: PubMed
    7. Lowenstein D. Decade in review-epilepsy: edging toward breakthroughs in epilepsy diagnostics and care. Nat Rev Neurol. 2015 11; 11(11):616-7. PMID: 26458286.
      View in: PubMed
    8. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein D. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 Oct; 56(10):1515-23. PMID: 26336950.
      View in: PubMed
    9. Rao VR, Lowenstein D. Epilepsy. Curr Biol. 2015 Aug 31; 25(17):R742-6. PMID: 26325130.
      View in: PubMed
    10. Betjemann JP, Josephson SA, Lowenstein D, Burke JF. Trends in Status Epilepticus-Related Hospitalizations and Mortality: Redefined in US Practice Over Time. JAMA Neurol. 2015 Jun; 72(6):650-5. PMID: 25915004.
      View in: PubMed
    11. Betjemann JP, Lowenstein D. Status epilepticus in adults. Lancet Neurol. 2015 Jun; 14(6):615-24. PMID: 25908090.
      View in: PubMed
    12. Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein D, Cascorbi I, Kroetz DL. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiol Dis. 2015 May; 77:127-40. PMID: 25766675; PMCID: PMC4404495.
    13. Welch RD, Nicholas K, Durkalski-Mauldin VL, Lowenstein D, Conwit R, Mahajan PV, Lewandowski C, Silbergleit R. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb; 56(2):254-62. PMID: 25597369; PMCID: PMC4386287.
    14. EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014; 4(95):360-70.
    15. Lowenstein D, Walker M, Waterhouse E. Status epilepticus in the setting of acute encephalitis. Epilepsy Curr. 2014 Jan; 14(1 Suppl):43-9. PMID: 24955075; PMCID: PMC3966644.
    16. Hegde M, Lowenstein D. The search for circulating epilepsy biomarkers. Biomark Med. 2014; 8(3):413-27. PMID: 24712433.
      View in: PubMed
    17. Hauser SL, Johnston SC, Ferriero DM, Josephson SA, Lowenstein D, Messing RO, Oksenberg JR. Quo vadis? Peering into the future. Ann Neurol. 2013 Dec; 74(6):A5-7. PMID: 24448838.
      View in: PubMed
    18. Aggarwal AK, Thompson M, Falik R, Shaw A, O'Sullivan P, Lowenstein D. Mental illness among us: a new curriculum to reduce mental illness stigma among medical students. Acad Psychiatry. 2013 Nov; 37(6):385-91. PMID: 24185285.
      View in: PubMed
    19. Johnston SC, Ferriero DM, Josephson SA, Lowenstein D, Messing RO, Oksenberg J, Stewart A, Hauser SL. Have the Annals editors added value? Ann Neurol. 2013 Nov; 74(5):A7-9. PMID: 24353220.
      View in: PubMed
    20. Widdess-Walsh P, Dlugos D, Fahlstrom R, Joshi S, Shellhaas R, Boro A, Sullivan J, Geller E. Lennox-Gastaut syndrome of unknown cause: phenotypic characteristics of patients in the Epilepsy Phenome/Genome Project. Epilepsia. 2013 Nov; 54(11):1898-904. PMID: 24116958.
      View in: PubMed
    21. Friedman D, Fahlstrom R. Racial and ethnic differences in epilepsy classification among probands in the Epilepsy Phenome/Genome Project (EPGP). Epilepsy Res. 2013 Dec; 107(3):306-10. PMID: 24139856; PMCID: PMC4176610.
    22. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J. The established status epilepticus trial 2013. Epilepsia. 2013 Sep; 54 Suppl 6:89-92. PMID: 24001084; PMCID: PMC4048827.
    23. Silbergleit R, Lowenstein D, Durkalski V, Conwit R. Lessons from the RAMPART study--and which is the best route of administration of benzodiazepines in status epilepticus. Epilepsia. 2013 Sep; 54 Suppl 6:74-7. PMID: 24001080; PMCID: PMC3767187.
    24. Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. Nature. 2013 Sep 12; 501(7466):217-21. PMID: 23934111; PMCID: PMC3773011.
    25. Fox CK, Glass HC, Sidney S, Lowenstein D, Fullerton HJ. Acute seizures predict epilepsy after childhood stroke. Ann Neurol. 2013 Aug; 74(2):249-56. PMID: 23613472; PMCID: PMC3830669.
    26. Abou-Khalil B, Alldredge B, Bautista J, Berkovic S, Bluvstein J, Boro A, Cascino G, Consalvo D, Cristofaro S, Crumrine P, Devinsky O, Dlugos D, Epstein M, Fahlstrom R, Fiol M, Fountain N, Fox K, French J, Freyer Karn C, Friedman D, Geller E, Glauser T, Glynn S, Haas K, Haut S, Hayward J, Helmers S, Joshi S, Kanner A, Kirsch H, Knowlton R, Kossoff E, Kuperman R, Kuzniecky R, Lowenstein D, McGuire S, Motika P, Nesbitt G, Novotny E, Ottman R, Paolicchi J, Parent J, Park K, Poduri A, Risch N, Sadleir L, Scheffer I, Shellhaas R, Sherr E, Shih JJ, Shinnar S, Singh R, Sirven J, Smith M, Sullivan J, Thio LL, Venkat A, Vining E, von Allmen G, Weisenberg J, Widdess-Walsh P, Winawer M. The epilepsy phenome/genome project. Clin Trials. 2013 Aug; 10(4):568-86. PMID: 23818435.
      View in: PubMed
    27. Shain C, Ramgopal S, Fallil Z, Parulkar I, Alongi R, Knowlton R, Poduri A. Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project. Epilepsia. 2013 Aug; 54(8):1368-75. PMID: 23750890; PMCID: PMC3851304.
    28. Hirose S, Scheffer IE, Marini C, De Jonghe P, Andermann E, Goldman AM, Kauffman M, Tan NC, Lowenstein D, Sisodiya SM, Ottman R, Berkovic SF. SCN1A testing for epilepsy: application in clinical practice. Epilepsia. 2013 May; 54(5):946-52. PMID: 23586701.
      View in: PubMed
    29. Helbig I, Lowenstein D. Genetics of the epilepsies: where are we and where are we going? Curr Opin Neurol. 2013 Apr; 26(2):179-85. PMID: 23429546; PMCID: PMC3781236.
    30. Winawer MR, Connors R. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia. 2013 Feb; 54(2):288-95. PMID: 23294289; PMCID: PMC3566298.
    31. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes. Epilepsia. 2012; 8(53):1457-67.
    32. Nesbitt G, McKenna K, Mays V, Carpenter A, Miller K, Williams M. The Epilepsy Phenome/Genome Project (EPGP) informatics platform. Int J Med Inform. 2013 Apr; 82(4):248-59. PMID: 22579394; PMCID: PMC3655424.
    33. Silbergleit R, Biros MH, Harney D, Dickert N, Baren J. Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience. Acad Emerg Med. 2012 Apr; 19(4):448-54. PMID: 22506949; PMCID: PMC3335290.
    34. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16; 366(7):591-600. PMID: 22335736; PMCID: PMC3307101.
    35. Stewart AF, Ferriero DM, Josephson SA, Lowenstein D, Messing RO, Oksenberg JR, Johnston SC, Hauser SL. Fighting decision fatigue. Ann Neurol. 2012 Jan; 71(1):A5-A15. PMID: 22275264.
      View in: PubMed
    36. Rossetti AO, Lowenstein D. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011 Oct; 10(10):922-30. PMID: 21939901; PMCID: PMC3202016.
    37. Silbergleit R, Lowenstein D, Durkalski V, Conwit R. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011 Oct; 52 Suppl 8:45-7. PMID: 21967361; PMCID: PMC3211107.
    38. Lowenstein D. Interview: the National Institute of Neurological Diseases and Stroke/American Epilepsy Society benchmarks and research priorities for epilepsy research. Biomark Med. 2011 Oct; 5(5):531-5. PMID: 22003901.
      View in: PubMed
    39. Mateen FJ, Carone M, Nyce S, Ghosn J, Mutuerandu T, Al-Saedy H, Lowenstein D, Burnham G. Neurological disorders in Iraqi refugees in Jordan: data from the United Nations Refugee Assistance Information System. J Neurol. 2012 Apr; 259(4):694-701. PMID: 21952870.
      View in: PubMed
    40. Durkalski V, Silbergleit R, Lowenstein D. Challenges in the design and analysis of non-inferiority trials: a case study. Clin Trials. 2011 Oct; 8(5):601-8. PMID: 21921062.
      View in: PubMed
    41. Josephson SA, Lowenstein D. Medical student learning in the preclinical curriculum: many steps behind a rapidly moving world. Ann Neurol. 2011 Jul; 70(1):A9-A10. PMID: 21786293.
      View in: PubMed
    42. Loring DW, Lowenstein D, Barbaro NM, Fureman BE, Odenkirchen J, Jacobs MP, Austin JK, Dlugos DJ, French JA, Gaillard WD, Hermann BP, Hesdorffer DC, Roper SN, Van Cott AC, Grinnon S, Stout A. Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project. Epilepsia. 2011 Jun; 52(6):1186-91. PMID: 21426327; PMCID: PMC3535455.
    43. Poduri A, Lowenstein D. Epilepsy genetics--past, present, and future. Curr Opin Genet Dev. 2011 Jun; 21(3):325-32. PMID: 21277190; PMCID: PMC4074083.
    44. Willmore LJ, Lowenstein D. Epilepsy and trauma: a persistent challenge. Neurology. 2010 Jul 20; 75(3):202-3. PMID: 20644147.
      View in: PubMed
    45. Hauser SL, Lowenstein D, Johnston SC. Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol. 2010 Feb; 67(2):A5-6. PMID: 20225263.
      View in: PubMed
    46. Hauser SL, Johnston SC, Ferriero DM, Lowenstein D, Josephson SA, Messing RO, Oksenberg JR, Stewart AF. Status report: the Annals in 2010. Ann Neurol. 2010 Jan; 67(1):A5-12. PMID: 20186980.
      View in: PubMed
    47. Lowenstein D. Traumatic brain injury: a glimpse of order among the chaos? Ann Neurol. 2009 Oct; 66(4):A7-8. PMID: 19847905.
      View in: PubMed
    48. Devinsky J, Lowenstein D, McElrea R. Harold Shaw and the Ross Sea Party: epilepsy in the Antarctic. J Hist Neurosci. 2009 Jul; 18(3):320-8. PMID: 20183212.
      View in: PubMed
    49. Kelley MS, Jacobs MP, Lowenstein D. The NINDS epilepsy research benchmarks. Epilepsia. 2009 Mar; 50(3):579-82. PMID: 19317887; PMCID: PMC2874963.
    50. Jacobs MP, Leblanc GG, Brooks-Kayal A, Jensen FE, Lowenstein D, Noebels JL, Spencer DD, Swann JW. Curing epilepsy: progress and future directions. Epilepsy Behav. 2009 Mar; 14(3):438-45. PMID: 19341977; PMCID: PMC2822433.
    51. Lowenstein D. Epilepsy after head injury: an overview. Epilepsia. 2009 Feb; 50 Suppl 2:4-9. PMID: 19187288.
      View in: PubMed
    52. Stern BJ, Lowenstein D, Schuh LA. Invited article: Neurology education research. Neurology. 2008 Mar 11; 70(11):876-83. PMID: 18332346.
      View in: PubMed
    53. Glaser CA, Gilliam S, Honarmand S, Tureen JH, Lowenstein D, Anderson LJ, Bollen AW, Solbrig MV. Refractory status epilepticus in suspect encephalitis. Neurocrit Care. 2008; 9(1):74-82. PMID: 18097641.
      View in: PubMed
    54. Lowenstein D, Messing R. Epilepsy genetics: yet more exciting news. Ann Neurol. 2007 Dec; 62(6):549-50. PMID: 17932953.
      View in: PubMed
    55. Shih T, Lowenstein D. Pharmacoresistant epilepsy: if at first you don't succeed... Ann Neurol. 2007 Oct; 62(4):311-3. PMID: 17932974.
      View in: PubMed
    56. Lowenstein D. Pathways to discovery in epilepsy research: rethinking the quest for cures. Epilepsia. 2008 Jan; 49(1):1-7. PMID: 17868052.
      View in: PubMed
    57. Johnston SC, Lowenstein D, Ferriero DM, Messing RO, Oksenberg JR, Hauser SL. Early editorial manuscript screening versus obligate peer review: a randomized trial. Ann Neurol. 2007 Apr; 61(4):A10-2. PMID: 17444512.
      View in: PubMed
    58. Lowenstein D, Cloyd J. Out-of-hospital treatment of status epilepticus and prolonged seizures. Epilepsia. 2007; 48 Suppl 8:96-8. PMID: 18330013.
      View in: PubMed
    59. Garga N, Lowenstein D. Posttraumatic epilepsy: a major problem in desperate need of major advances. Epilepsy Curr. 2006 Jan-Feb; 6(1):1-5. PMID: 16477313; PMCID: PMC1363374.
    60. Parent JM, von dem Bussche N, Lowenstein D. Prolonged seizures recruit caudal subventricular zone glial progenitors into the injured hippocampus. Hippocampus. 2006; 16(3):321-8. PMID: 16435310.
      View in: PubMed
    61. Lowenstein D. The management of refractory status epilepticus: an update. Epilepsia. 2006; 47 Suppl 1:35-40. PMID: 17044824.
      View in: PubMed
    62. Parent JM, Elliott RC, Pleasure SJ, Barbaro NM, Lowenstein D. Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann Neurol. 2006 Jan; 59(1):81-91. PMID: 16261566.
      View in: PubMed
    63. Lowenstein D. Treatment options for status epilepticus. Curr Opin Pharmacol. 2005 Jun; 5(3):334-9. PMID: 15907922.
      View in: PubMed
    64. Del Turco D, Gebhardt C, Burbach GJ, Pleasure SJ, Lowenstein D, Deller T. Laminar organization of the mouse dentate gyrus: insights from BETA2/Neuro D mutant mice. J Comp Neurol. 2004 Sep 06; 477(1):81-95. PMID: 15281081.
      View in: PubMed
    65. Irby DM, Cooke M, Lowenstein D, Richards B. The academy movement: a structural approach to reinvigorating the educational mission. Acad Med. 2004 Aug; 79(8):729-36. PMID: 15277127.
      View in: PubMed
    66. Elliott RC, Lowenstein D. Gene expression profiling of seizure disorders. Neurochem Res. 2004 Jun; 29(6):1083-92. PMID: 15176465.
      View in: PubMed
    67. Cao X, Wong ST, Hoo KS, Tjandra D, Fu JC, Lowenstein D. A web-based federated neuroinformatics model for surgical planning and clinical research applications in epilepsy. Neuroinformatics. 2004; 2(1):101-18. PMID: 15067170.
      View in: PubMed
    68. Chang BS, Lowenstein D. Epilepsy. N Engl J Med. 2003 Sep 25; 349(13):1257-66. PMID: 14507951.
      View in: PubMed
    69. Thibault GE, Neill JM, Lowenstein D. The Academy at Harvard Medical School: nurturing teaching and stimulating innovation. Acad Med. 2003 Jul; 78(7):673-81. PMID: 12857684.
      View in: PubMed
    70. Elliott RC, Miles MF, Lowenstein D. Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci. 2003 Mar 15; 23(6):2218-27. PMID: 12657681.
      View in: PubMed
    71. Lowenstein D. Treatment options for status epilepticus. Curr Opin Pharmacol. 2003 Feb; 3(1):6-11. PMID: 12550735.
      View in: PubMed
    72. Chang BS, Lowenstein D. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003 Jan 14; 60(1):10-6. PMID: 12525711.
      View in: PubMed
    73. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Loscher W, Lowenstein D, Moshe SL, Noebels JL, Davis M. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia. 2002 Nov; 43(11):1410-20. PMID: 12423393.
      View in: PubMed
    74. Rider EA, Cooke M, Lowenstein D. The Academies Collaborative: sharing a new model for medical education. Acad Med. 2002 May; 77(5):455. PMID: 12010711.
      View in: PubMed
    75. Parent JM, Valentin VV, Lowenstein D. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci. 2002 Apr 15; 22(8):3174-88. PMID: 11943819.
      View in: PubMed
    76. Parent JM, Lowenstein D. Seizure-induced neurogenesis: are more new neurons good for an adult brain? Prog Brain Res. 2002; 135:121-31. PMID: 12143334.
      View in: PubMed
    77. Lowenstein D. Epilepsy after head injury: the impact of impact. Ann Neurol. 2001 Dec; 50(6):696-7. PMID: 11761465.
      View in: PubMed
    78. Jacobs MP, Fischbach GD, Davis MR, Dichter MA, Dingledine R, Lowenstein D, Morrell MJ, Noebels JL, Rogawski MA, Spencer SS, Theodore WH. Future directions for epilepsy research. Neurology. 2001 Nov 13; 57(9):1536-42. PMID: 11706087.
      View in: PubMed
    79. Castro PA, Cooper EC, Lowenstein D, Baraban SC. Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. J Neurosci. 2001 Sep 01; 21(17):6626-34. PMID: 11517252.
      View in: PubMed
    80. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein D. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001 Aug 30; 345(9):631-7. PMID: 11547716.
      View in: PubMed
    81. Lowenstein D, Alldredge BK, Allen F, Neuhaus J, Corry M, Gottwald M, O'Neil N, Ulrich S, Isaacs SM, Gelb A. The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials. 2001 Jun; 22(3):290-309. PMID: 11384791.
      View in: PubMed
    82. Kim AS, Lowenstein D, Pleasure SJ. Wnt receptors and Wnt inhibitors are expressed in gradients in the developing telencephalon. Mech Dev. 2001 May; 103(1-2):167-72. PMID: 11335128.
      View in: PubMed
    83. Kim AS, Anderson SA, Rubenstein JL, Lowenstein D, Pleasure SJ. Pax-6 regulates expression of SFRP-2 and Wnt-7b in the developing CNS. J Neurosci. 2001 Mar 01; 21(5):RC132. PMID: 11222670.
      View in: PubMed
    84. Elliott RC, Khademi S, Pleasure SJ, Parent JM, Lowenstein D. Differential regulation of basic helix-loop-helix mRNAs in the dentate gyrus following status epilepticus. Neuroscience. 2001; 106(1):79-88. PMID: 11564418.
      View in: PubMed
    85. Lowenstein D. Structural reorganization of hippocampal networks caused by seizure activity. Int Rev Neurobiol. 2001; 45:209-36. PMID: 11130900.
      View in: PubMed
    86. Pleasure SJ, Anderson S, Hevner R, Bagri A, Marin O, Lowenstein D, Rubenstein JL. Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron. 2000 Dec; 28(3):727-40. PMID: 11163262.
      View in: PubMed
    87. Pleasure SJ, Collins AE, Lowenstein D. Unique expression patterns of cell fate molecules delineate sequential stages of dentate gyrus development. J Neurosci. 2000 Aug 15; 20(16):6095-105. PMID: 10934259.
      View in: PubMed
    88. Liu M, Pleasure SJ, Collins AE, Noebels JL, Naya FJ, Tsai MJ, Lowenstein D. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci U S A. 2000 Jan 18; 97(2):865-70. PMID: 10639171; PMCID: PMC15422.
    89. Lado FA, Sankar R, Lowenstein D, Moshé SL. Age-dependent consequences of seizures: relationship to seizure frequency, brain damage, and circuitry reorganization. Ment Retard Dev Disabil Res Rev. 2000; 6(4):242-52. PMID: 11107189.
      View in: PubMed
    90. Chen H, Bagri A, Zupicich JA, Zou Y, Stoeckli E, Pleasure SJ, Lowenstein D, Skarnes WC, Chédotal A, Tessier-Lavigne M. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron. 2000 Jan; 25(1):43-56. PMID: 10707971.
      View in: PubMed
    91. Tada E, Parent JM, Lowenstein D, Fike JR. X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience. 2000; 99(1):33-41. PMID: 10924950.
      View in: PubMed
    92. Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, Fields SM, Lowenstein D, Alldredge BK. Prehospital stability of diazepam and lorazepam. Am J Emerg Med. 1999 Jul; 17(4):333-7. PMID: 10452426.
      View in: PubMed
    93. Parent JM, Tada E, Fike JR, Lowenstein D. Inhibition of dentate granule cell neurogenesis with brain irradiation does not prevent seizure-induced mossy fiber synaptic reorganization in the rat. J Neurosci. 1999 Jun 01; 19(11):4508-19. PMID: 10341251.
      View in: PubMed
    94. Alldredge BK, Lowenstein D. Status epilepticus: new concepts. Curr Opin Neurol. 1999 Apr; 12(2):183-90. PMID: 10226751.
      View in: PubMed
    95. Lowenstein D, Parent JM. Brain, heal thyself. Science. 1999 Feb 19; 283(5405):1126-7. PMID: 10075572.
      View in: PubMed
    96. Lowenstein D, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia. 1999 Jan; 40(1):120-2. PMID: 9924914.
      View in: PubMed
    97. Lowenstein D. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999; 40 Suppl 1:S3-8; discussion S21-2. PMID: 10421556.
      View in: PubMed
    98. Parent JM, Janumpalli S, McNamara JO, Lowenstein D. Increased dentate granule cell neurogenesis following amygdala kindling in the adult rat. Neurosci Lett. 1998 May 08; 247(1):9-12. PMID: 9637397.
      View in: PubMed
    99. Drake MV, Lowenstein D. The role of diversity in the health care needs of California. West J Med. 1998 May; 168(5):348-54. PMID: 9614792; PMCID: PMC1304978.
    100. Lowenstein D, Alldredge BK. Status epilepticus. N Engl J Med. 1998 Apr 02; 338(14):970-6. PMID: 9521986.
      View in: PubMed
    101. Lowenstein D. Status epilepticus. West J Med. 1998 Apr; 168(4):263. PMID: 9584666; PMCID: PMC1304953.
    102. Cooper EC, Milroy A, Jan YN, Jan LY, Lowenstein D. Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus. J Neurosci. 1998 Feb 01; 18(3):965-74. PMID: 9437018.
      View in: PubMed
    103. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein D. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci. 1997 May 15; 17(10):3727-38. PMID: 9133393.
      View in: PubMed
    104. Parent JM, Lowenstein D. Mossy fiber reorganization in the epileptic hippocampus. Curr Opin Neurol. 1997 Apr; 10(2):103-9. PMID: 9146991.
      View in: PubMed
    105. Lowenstein D, Arsenault L. Dentate granule cell layer collagen explant cultures: spontaneous axonal growth and induction by brain-derived neurotrophic factor or basic fibroblast growth factor. Neuroscience. 1996 Oct; 74(4):1197-208. PMID: 8895886.
      View in: PubMed
    106. Lowenstein D, Arsenault L. The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J Neurosci. 1996 Mar 01; 16(5):1759-69. PMID: 8774444.
      View in: PubMed
    107. Lowenstein D. Recent advances related to basic mechanisms of epileptogenesis. Epilepsy Res Suppl. 1996; 11:45-60. PMID: 9294727.
      View in: PubMed
    108. Holtzman DM, Lowenstein D. Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy. J Neurosci. 1995 Nov; 15(11):7062-70. PMID: 7472461.
      View in: PubMed
    109. Raghupathi R, Welsh FA, Lowenstein D, Gennarelli TA, McIntosh TK. Regional induction of c-fos and heat shock protein-72 mRNA following fluid-percussion brain injury in the rat. J Cereb Blood Flow Metab. 1995 May; 15(3):467-73. PMID: 7714005.
      View in: PubMed
    110. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein D, Dallman MF, Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995 Apr 06; 374(6522):542-6. PMID: 7700379.
      View in: PubMed
    111. Lowenstein D. The stress protein response and its potential relationship to prolonged seizure activity. Clin Neuropharmacol. 1995 Apr; 18(2):148-58. PMID: 8635174.
      View in: PubMed
    112. Parent JM, Lowenstein D. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology. 1994 Oct; 44(10):1837-40. PMID: 7936232.
      View in: PubMed
    113. Lowenstein D, Gwinn RP, Seren MS, Simon RP, McIntosh TK. Increased expression of mRNA encoding calbindin-D28K, the glucose-regulated proteins, or the 72 kDa heat-shock protein in three models of acute CNS injury. Brain Res Mol Brain Res. 1994 Mar; 22(1-4):299-308. PMID: 8015387.
      View in: PubMed
    114. Smith DH, Lowenstein D, Gennarelli TA, McIntosh TK. Persistent memory dysfunction is associated with bilateral hippocampal damage following experimental brain injury. Neurosci Lett. 1994 Feb 28; 168(1-2):151-4. PMID: 8028769.
      View in: PubMed
    115. Lowenstein D. Basic concepts of molecular biology for the epileptologist. Epilepsia. 1994; 35 Suppl 1:S7-19. PMID: 8293725.
      View in: PubMed
    116. Alldredge BK, Lowenstein D. Status epilepticus related to alcohol abuse. Epilepsia. 1993 Nov-Dec; 34(6):1033-7. PMID: 8243353.
      View in: PubMed
    117. Lowenstein D, Seren MS, Longo FM. Prolonged increases in neurotrophic activity associated with kainate-induced hippocampal synaptic reorganization. Neuroscience. 1993 Oct; 56(3):597-604. PMID: 8255423.
      View in: PubMed
    118. Devinsky O, Lowenstein D, Bromfield E, Duchowny M, Smith DB. Epilepsy education in medical schools: report of the American Epilepsy Society Committee on Medical Student Education. Epilepsia. 1993 Sep-Oct; 34(5):809-11. PMID: 8404729.
      View in: PubMed
    119. Eide FF, Lowenstein D, Reichardt LF. Neurotrophins and their receptors--current concepts and implications for neurologic disease. Exp Neurol. 1993 Jun; 121(2):200-14. PMID: 8339771.
      View in: PubMed
    120. Yaffe K, Lowenstein D. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology. 1993 May; 43(5):895-900. PMID: 8492944.
      View in: PubMed
    121. Lowenstein D, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993 Mar; 43(3 Pt 1):483-8. PMID: 8450988.
      View in: PubMed
    122. Hicks RR, Smith DH, Lowenstein D, Saint Marie R, McIntosh TK. Mild experimental brain injury in the rat induces cognitive deficits associated with regional neuronal loss in the hippocampus. J Neurotrauma. 1993; 10(4):405-14. PMID: 8145264.
      View in: PubMed
    123. Lowenstein D, Thomas MJ, Smith DH, McIntosh TK. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci. 1992 Dec; 12(12):4846-53. PMID: 1464770.
      View in: PubMed
    124. Sloviter RS, Lowenstein D. Heat shock protein expression in vulnerable cells of the rat hippocampus as an indicator of excitation-induced neuronal stress. J Neurosci. 1992 Aug; 12(8):3004-9. PMID: 1494943.
      View in: PubMed
    125. Täuber MG, Kennedy SL, Tureen JH, Lowenstein D. Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am J Pathol. 1992 Jul; 141(1):53-60. PMID: 1632471; PMCID: PMC1886581.
    126. Tsaur ML, Sheng M, Lowenstein D, Jan YN, Jan LY. Differential expression of K+ channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures. Neuron. 1992 Jun; 8(6):1055-67. PMID: 1610565.
      View in: PubMed
    127. Lowenstein D, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992 Jan; 42(1):100-4. PMID: 1734288.
      View in: PubMed
    128. Lowenstein D, Chan PH, Miles MF. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron. 1991 Dec; 7(6):1053-60. PMID: 1764242.
      View in: PubMed
    129. Lowenstein D, Shimosaka S, So YT, Simon RP. The relationship between electrographic seizure activity and neuronal injury. Epilepsy Res. 1991 Oct; 10(1):49-54. PMID: 1790772.
      View in: PubMed
    130. Sharp FR, Sagar SM, Hicks K, Lowenstein D, Hisanaga K. c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress. J Neurosci. 1991 Aug; 11(8):2321-31. PMID: 1908006.
      View in: PubMed
    131. Sharp FR, Lowenstein D, Simon R, Hisanaga K. Heat shock protein hsp72 induction in cortical and striatal astrocytes and neurons following infarction. J Cereb Blood Flow Metab. 1991 Jul; 11(4):621-7. PMID: 2050750.
      View in: PubMed
    132. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein D, Aminoff MJ. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol. 1991 Apr; 29(4):370-6. PMID: 1929208.
      View in: PubMed
    133. Lowenstein D, Miles MF, Hatam F, McCabe T. Up regulation of calbindin-D28K mRNA in the rat hippocampus following focal stimulation of the perforant path. Neuron. 1991 Apr; 6(4):627-33. PMID: 2015095.
      View in: PubMed
    134. Simon RP, Cho H, Gwinn R, Lowenstein D. The temporal profile of 72-kDa heat-shock protein expression following global ischemia. J Neurosci. 1991 Mar; 11(3):881-9. PMID: 2002365.
      View in: PubMed
    135. Gonzalez MF, Lowenstein D, Fernyak S, Hisanaga K, Simon R, Sharp FR. Induction of heat shock protein 72-like immunoreactivity in the hippocampal formation following transient global ischemia. Brain Res Bull. 1991 Feb; 26(2):241-50. PMID: 2012984.
      View in: PubMed
    136. Lowenstein D, Alldredge B. Managing status epilepticus. Lancet. 1990 Dec 08; 336(8728):1451. PMID: 1978912.
      View in: PubMed
    137. Kaku DA, Lowenstein D. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med. 1990 Dec 01; 113(11):821-7. PMID: 2240897.
      View in: PubMed
    138. Lowenstein D, Simon RP, Sharp FR. The pattern of 72-kDa heat shock protein-like immunoreactivity in the rat brain following flurothyl-induced status epilepticus. Brain Res. 1990 Oct 29; 531(1-2):173-82. PMID: 2289119.
      View in: PubMed
    139. Lowenstein D, Butler DA, Westaway D, McKinley MP, DeArmond SJ, Prusiner SB. Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol Cell Biol. 1990 Mar; 10(3):1153-63. PMID: 2406562; PMCID: PMC360985.
    140. Rowbotham MC, Lowenstein D. Neurologic consequences of cocaine use. Annu Rev Med. 1990; 41:417-22. PMID: 2184741.
      View in: PubMed
    141. Alldredge BK, Lowenstein D, Simon RP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med. 1989 Dec; 87(6):645-8. PMID: 2686433.
      View in: PubMed
    142. Alldredge BK, Lowenstein D, Simon RP. Seizures associated with recreational drug abuse. Neurology. 1989 Aug; 39(8):1037-9. PMID: 2788249.
      View in: PubMed
    143. Engstrom JW, Lowenstein D, Bredesen DE. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med. 1989 May; 86(5):528-32. PMID: 2712060.
      View in: PubMed
    144. Lowenstein D. Recreational drugs and stroke in young adults. West J Med. 1989 May; 150(5):575-6. PMID: 18750581.
      View in: PubMed
    145. Rowley HA, Lowenstein D, Rowbotham MC, Simon RP. Thalamomesencephalic strokes after cocaine abuse. Neurology. 1989 Mar; 39(3):428-30. PMID: 2927656.
      View in: PubMed
    146. Gelb DJ, Lowenstein D, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology. 1989 Jan; 39(1):80-4. PMID: 2642616.
      View in: PubMed
    147. Olney RK, Aminoff MJ, Gelb DJ, Lowenstein D. Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology. 1988 Nov; 38(11):1780-3. PMID: 2847080.
      View in: PubMed
    148. Charman HP, Lowenstein D, Cho KG, DeArmond SJ, Wilson CB. Primary cerebral angiosarcoma. Case report. J Neurosurg. 1988 May; 68(5):806-10. PMID: 3357039.
      View in: PubMed
    149. Lowenstein D, Aminoff MJ. The clinical course of spasmodic torticollis. Neurology. 1988 Apr; 38(4):530-2. PMID: 3352905.
      View in: PubMed
    150. Lowenstein D, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology. 1988 Mar; 38(3):395-400. PMID: 3279338.
      View in: PubMed
    151. Lowenstein D, Massa SM, Rowbotham MC, Collins SD, McKinney HE, Simon RP. Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med. 1987 Nov; 83(5):841-6. PMID: 3674091.
      View in: PubMed
    152. Lowenstein D, Mills C, Simon RP. Acute syphilitic transverse myelitis: unusual presentation of meningovascular syphilis. Genitourin Med. 1987 Oct; 63(5):333-8. PMID: 3679219; PMCID: PMC1194104.
    153. Lowenstein D, Koch TK, Edwards MS. Cerebral ptosis with contralateral arteriovenous malformation: a report of two cases. Ann Neurol. 1987 Apr; 21(4):404-7. PMID: 3579226.
      View in: PubMed
    Daniel's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP